NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Written by / Agency / Source: Medimix International
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Medimix Announces ScanBuzz™ – First Social Media Monitoring Platform for the Lifesciences Industries - Medimix International announced the launch of a new platform for social media monitoring, designed with pharmaceutical, biotech, and medical device industries in mind--an invaluable aid for listening to the chatter in the international marketplace
Medimix Announces ScanBuzz™ – First Social Media Monitoring Platform for the Lifesciences Industries

 

NewswireToday - /newswire/ - Miami, FL, United States, 2009/12/02 - Medimix International announced the launch of a new platform for social media monitoring, designed with pharmaceutical, biotech, and medical device industries in mind--an invaluable aid for listening to the chatter in the international marketplace.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Medimix International has developed and is announcing the launch of ScanBuzz™, the first platform for life sciences companies to monitor online mentions of their brands and products in the social networking arena. With the increased number of physicians and patients sharing their experiences online, Scanbuzz™ allows the industry to discover, listen, and manage feedback and develop relations with social network users.

From forums to blogs, social networks to multimedia sharing websites, Twitter to YouTube, and more, ScanBuzz™ uncovers online conversations and gives companies the tools to track, analyze, manage, monitor, and report on their social media engagement activities.

As more users openly discuss drugs and healthcare issues, social media increasingly affects all the processes within the enterprise, including marketing, public relations, customer support, product development, competitive intelligence, as well as legal and medical. ScanBuzz™ helps life sciences companies discover and listen to what healthcare professionals and patients are saying about them and to act on these mentions.

With Scanbuzz™, Medimix International (medimix.net) currently tracks the top 200 pharmaceutical products and 100 corporate brands. Scanbuzz™ tracks in a variety of therapeutic areas from oncology to respiratory, CNS, diabetes and endocrinology. Clients can also monitor their own choice of brands, disease or conditions, therapeutic areas, or any concept they are interested in.

“For the first time ever, drug manufacturers have the opportunity to monitor the word-of-mouth happening among patients, or between patients and healthcare professionals. Customers are now more vocal and accessible than ever before, and life sciences companies must address the new expectations and needs of the social physician and patient. ScanBuzz™ equips pharmaceutical teams with essential social media listening, management and reporting capabilities,” says Henry Gazay, CEO of Medimix international.

For example, Scanbuzz™ uncovered that the amount of online discussions on a particular oncology product increased five-fold during the ESMO conference last September, which gave the manufacturer of the drug an immediate indication about their Return on Investment (ROI) at this congress. Also, on the day when the Pfizer-Wyeth merger became effective (October 15th 2009), Scanbuzz™ recorded a four-fold surge in buzz about Wyeth, with patients and employees tweeting their concerns about the merger, and financial traders blogging about the impact it would have on the short to mid-term value of Pfizer’s stock.

“With Scanbuzz™ drug manufacturers are able to provide new levels of satisfaction and service by listening to their customers online and responding to them. They can also set alerts to help them anticipate competitors’ moves, prevent crises and track rumors,” remarks Alex de Carvalho, Social Media Director at Medimix International, and co-developer of Scanbuzz™.

The ScanBuzz™ platform provides Life Sciences companies with the following:

• Marketing teams have access to more pertinent information about their customers through their online discussions;

• Marketing Research departments can monitor daily the number of comments posted about their brands or their competitors in blogs, forums and social networking sites;

• Sales teams can identify and meet prospective, influential physicians, reducing the overall cost of qualified leads;

• Medical support teams can proactively respond to patients, based on a better understanding of their issues;

• Public relations, advertising and communications teams understand new contexts for their outreach activities;

• Community management teams can measure and evaluate the types of social media platforms and communities that are most effective in generating influential word-of-mouth;

• Investors can anticipate the impact of recent news, such as results of clinical trials or announcements of M&A.

Scanbuzz™ is available through a small monthly subscription fee, based on the number of simultaneous users and the number of brands tracked.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Medimix International

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Medimix Announces ScanBuzz™ – First Social Media Monitoring Platform for the Lifesciences Industries

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Kathryn McAdam - Medimix.net 
305-573-5233 kmcadam[.]medimix.net
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Medimix International securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Medimix International / Company Profile


Read Health / Surgery Most Recent Related Newswires:

InterSystems Partners with the Rhodes Group to Improve Hepatitis C Treatment in New Mexico
BostonGene Announces 0 Million Series B Funding at a Multi-Billion Dollar Valuation, Propelling the Company to Unicorn Status
Research Grant Awarded for Low-Grade Ovarian Cancer Study
Roche Diagnostics India Earns the Frost & Sullivan 2021 India Competitive Strategy Leadership Award
Wolters Kluwer Lauded by Frost & Sullivan for Enabling Aligned Decision-making with its Clinical Decision Support Solutions
Syapse Awarded 2021 Technology Innovation Leadership Award by Frost & Sullivan for Accelerating Real-world Care Delivery
Lumeon Commended by Frost & Sullivan for Enabling Digital Transformation in Healthcare
Payment Integrity Solutions Enable Healthcare Plans to Optimize Processes and Maximize Returns Finds Frost & Sullivan
Menopause to Become the Next Game-changer in the Global Femtech Solutions Industry by 2025 Finds Frost & Sullivan
Innovative MedTech Business Models Will Enable Cost-effective, Decentralized and Patient-centric Care Finds Frost & Sullivan
Data Monetization a Must for MedTech Industry to Evolve Toward Real-World Evidence and Precision Medicine Finds Frost & Sullivan
InterSystems Partners with Cognetivity on Ground-breaking AI Solution for Early Dementia Detection
Humimic Medical, Partners Team Up to Make A Difference in South Carolina COVID Battle
Adoption of HaH Model Surged Eight-fold with the Availability of Advanced Remote Monitoring and Digital Health Solutions Finds Frost & Sullivan
Major Innovation Announcement Planned, SC Life Sciences Conference Shatters Registration Record

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2022 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)